Nordihydroguaiaretic acid affects multiple dynein-dynactin functions in interphase and mitotic cells

Molecular Pharmacology

Volumn 71, Issue 2, 2007, Pages 454-460

  Arasaki, Kohei ^a   Tani, Katsuko ^a   Yoshimori, Tamotsu ^b   Stephens, David J ^c   Tagaya, Mitsuo ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; DYNACTIN; DYNEIN ADENOSINE TRIPHOSPHATASE; NOCODAZOLE; NORDIHYDROGUAIARETIC ACID; PROTEIN EB1; PROTEIN ZW10; UNCLASSIFIED DRUG;

ARTICLE; CENTROSOME; COMPLEX FORMATION; CONTROLLED STUDY; DEPOLYMERIZATION; ENDOCYTOSIS; GOLGI COMPLEX; HUMAN; HUMAN CELL; INTERPHASE; INTRACELLULAR TRANSPORT; MICROTUBULE; MITOSIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SPINDLE POLE BODY;

CENTROSOME; DYNEIN ATPASE; GOLGI APPARATUS; HELA CELLS; HUMANS; INTERPHASE; LIPOXYGENASE INHIBITORS; MICROTUBULE-ASSOCIATED PROTEINS; MICROTUBULES; MITOSIS; MITOTIC SPINDLE APPARATUS; MOLECULAR MOTOR PROTEINS; NORDIHYDROGUAIARETIC ACID; PROTEIN TRANSPORT; TRANSDUCTION, GENETIC;

EID: 33846435699     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.106.029611     Document Type: Article

References (40)

1. Avis IM, Jett M, Boyle T, Vos MD, Moody T, Treston AM, Martinez A, and Mulshine JL (1996) Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling. J Clin Investig 197:806-813.
2. Bergstralh DT and Ting JPY (2006) Microtubule stabilizing agents: their molecular signaling consequences and the potential for enhancement by drug combination. Cancer Treat Rev 32:166-179.
3. Berrueta L, Tirnauer JS, Schuyler SC, Pellman D, and Bierer BE (1999) The APC-associated protein EB1 associates with components of the dynactin complex and cytoplasmic dynein intermediate chain. Curr Biol 9:425-428.
4. Burkhardt JK, Echeverri CJ, Nilsson T, and Vallee RB (1997) Overexpression of the dynamitin (p50) subunit of the dynactin complex disrupts dynein-dependent maintenance of membrane organelle distribution. J Cell Biol 139:469-484.
5. Carvalho P, Tirnauer JS, and Pellman D (2003) Surfing on microtubule ends. Trends Cell Biol 13:229-237.
6. Chan GKT, Jablonski SA, Starr DA, Goldberg ML, and Yen TJ (2000) Human Zw10 and ROD are mitotic checkpoint proteins that bind to kinetochores. Nat Cell Biol 2:944-947.
7. Cole NB, Smith CL, Sciaky N, Terasaki M, Edidin M, and Lippincott-Schwartz J (1996) Diffusional mobility of Golgi proteins in membranes of living cells. Science (Wash DC) 273:797-801.
8. Culver-Hanlon TL, Lex SA, Stephens AD, Quintyne NJ, and King SJ (2006) A microtubule-binding domain in dynactin increases dynein processivity by skating along microtubules. Nat Cell Biol 8:264-270.
9. Domin J, Higgins T, and Rozengurt E (1994) Preferential inhibition of platelet-derived growth factor-stimulated DNA synthesis and protein tyrosine phosphorylation by nordihydroguaiaretic acid. J Biol Chem 269:8260-8267.
10. Dong C, Li Z, Alvarez R Jr, Feng XH, and Goldschmidt-Clemont PJ (2000) Micorotubule binding to Smads may regulate TGF-β activity. Mol Cell 5:27-34.
11. Drecktrah D, de Figueiredo P, Mason RM, and Brown WJ (1998) Retrograde trafficking of both Golgi complex and TGN markers to the ER induced by nordihydroguaiaretic acid and cyclofenil diphenol. J Cell Sci 111:951-965.
12. Fujiwara T, Takami N, Misumi Y, and Ikehara Y (1998a) Nordihydroguaiaretic acid blocks protein transport in the secretory pathway causing redistribution of Golgi proteins into the endoplasmic reticulum. J Biol Chem 273:3068-3075.
13. Fujiwara T, Misumi Y, and Ikehara Y (1998b) Dynamic recycling of ERGIC53 between the endoplasmic reticulum and the Golgi complex is disrupted by nordihydroguaiaretic acid. Biochem Biophys Res Commun 253:869-876.
14. Fujiwara T, Misumi Y, and Ikehara Y (2003) Direct interaction of the Golgi membrane with the endoplasmic reticulum membrane caused by nordihydroguaiaretic acid. Biochem Biophys Res Commun 301:927-933.
15. Gnabre JN, Brady JN, Clanton DJ, Ito Y, Dittmer J, Bates RB, and Huang RC (1995) Inhibition of human immunodeficiency virus type 1 transcription and replication by DNA sequence-selective plant lignans. Proc Natl Acad Sci USA 92:11239-11243.
16. Goetzl EJ (1980) A role for endogenous mono-hydroxy-eicosatetraenoic acids (HETEs) in the regulation of human neutrophil migration. Immunology 40:709-719.
17. Green RA, Wollman R, and Kaplan KB (2005) APC and EB1 function together in mitosis to regulate spindle dynamics and chromosome alignment. Mol Biol Cell 16:4609-4622.
18. Gundersen GG and Cook TA (1999) Microtubules and signal transduction. Curr Opin Cell Biol 11:81-94.
19. Habermann A, Schoroer TA, Griffiths G, and Burkhardt JK (2000) Immunolocalization of cytoplasmic dynein and dynactin subunits in cultured macrophages: enrichment on early endocytotic organelles. J Cell Sci 114:229-240.
20. Hirose H, Arasaki K, Dohmae N, Takio K, Hatsuzawa K, Nagahama M, Tani K, Yamamoto A, Tohyama M, and Tagaya M (2004) Implication of ZW10 in membrane trafficking between the endoplasmic reticulum and Golgi. EMBO (Eur Mol Biol Organ) J 23:1267-1278.
21. 2+ handling and cytotoxicity in human prostate cancer cells. Life Sci 5:2341-2351.
22. Ito H, Ueda H, Iwamoto I, Inaguma Y, Takizawa T, Asano T, and Kato K (2005) Nordihydroguaiaretic acid (NDGA) blocks the differentiation of C2C12 myoblast cells. J Cell Physiol 202:874-879.
23. 2+ currents independently of lipoxygenase inhibition. Mol Pharmacol 38:524-530.
24. Lee CH, Jang YS, Her SJ, Moon YM, Baek SJ, and Eling T (2003) Nordihydroguaiaretic acid, an antioxidant, inhibits transforming growth factor-beta activity through the inhibition of Smad signaling pathway. Exp Cell Res 289:335-341.
25. McDonald RW, Bunjobpon W, Liu T, Fessler S, Pardo OE, Freer IK, Glaser M, Seckl MJ, and Robins DJ (2001) Synthesis and anticancer activity of nordihydroguaiaretic acid (NDGA) and analogues. Anticancer Drug Des 16:261-270.
26. Moss MA, Varvel NH, Nichols MR, Reed DK, and Rosenberry TL (2004) Nordihydroguaiaretic acid does not disaggregate β-amyloid(1-40) protofibrils but does inhibit growth arising from direct protofibril association. Mol Pharmcol 66:592-600.
27. Nakamura M, Nakazawa J, Usui T, Osada H, Kono Y, and Takatsuki A (2003) Nordihydroguaiaretic acid, of a new family of microtubule-stabilizing agents, shows effects differentiated from paclitaxel. Biosci Biotechnol Biochem 67:151-157.
28. Niclas J, Allan VJ, and Vale RD (1996) Cell cycle regulation of dynein association with membranes modulates microtubule-based organelle transport. J Cell Biol 133:585-593.
29. Ramasamy S, Drummond GR, Ahn J, Storek M, Pohl J, Parthasarathy S, and Harrison DG (1999) Modulation of expression of endothelial nitric oxide synthase by nordihydroguaiaretic acid, a phenolic antioxidant in cultured endothelial cells. Mol Pharmacol 56:116-123.
30. Ramoner R, Rieser C, Bartsch G, and Thurnher M (1998) Nordihydroguaiaretic acid blocks secretory and endocytic pathways in human dendritic cells. J Leukoc Biol 164:747-752.
31. Sager PR, Brown PA, and Berlin RD (1984) Analysis of transferrin recycling in mitotic and interphase HeLa cells by quantitative fluorescence microscopy. Cell 39:275-282.
32. Starr DA, Williams BC, Hays TS, and Goldberg ML (1998) ZW10 helps recruit dynactin and dynein to the kinetochore. J Cell Biol 142:763-774.
33. Seufferlein T, Seckl MJ, Schwarz E, Beil M, v Wichert G, Baust H, Luhrs H, Schmid RM, and Adler G (2002) Mechanisms of nordihydroguaiaretic acid-induced growth inhibition and apoptosis in human cancer cells. Br J Cancer 86:1188-1196.
34. 2 activity and intra-Golgi protein transport reconstituted in a cell-free system. FEBS Lett 324:201-204.
35. Tagaya M, Henomatsu N, Yoshimori T, Yamamoto A, Tashiro Y, and Mizushima S (1996) Inhibition of vesicle-mediated protein transport by nordihydroguaiaretic acid. J Biochem 119:863-869.
36. West M, Mhatre M, Ceballos A, Floyd RA, Grammas P, Gabbita SP, Hamdheydari L, Mai T, Mou S, Pye QN, et al. (2004) The arachidonic acid 5-lipoxygenase inhibitor nordihydroguaiaretic acid inhibits tumor necrosis factor alpha activation of microglia and extends survival of G93A-SOD1 transgenic mice. J Neurochem 91:133-143.
37. Yamaguchi T, Yamamoto A, Furuno A, Hatsuzawa K, Tani K, Himeno M, and Tagaya M (1997) Possible involvement of heterotrimeric G proteins in the organization of the Golgi apparatus. J Biol Chem 272:25260-25266.
38. Yoshimori T, Shimonishi Y, and Uchida T (1988) Binding properties of monoclonal antibody to the cytoplasmic domain of transferrin receptor. Cell Struct Funct 113:311-324.
39. Youngren JF, Gable K, Penaranda C, Maddux BA, Zavodovskaya M, Lobo M, Campbell M, Kerner J, and Goldfine ID (2005) Nordihydroguaiaretic acid (NDGA) inhibits the IGF-1 and c-erbB2/HER2/neu receptors and suppresses growth in breast cancer cells. Breast Cancer Res Treat 94:37-46.
40. Yvon AM, Wadsworth P, and Jordan MA (1999) Taxol suppresses dynamics of individual microtubules in living human tumor cells. Mol Biol Cell 10:947-959.